BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22795313)

  • 1. Targeting of TAK1 in inflammatory disorders and cancer.
    Sakurai H
    Trends Pharmacol Sci; 2012 Oct; 33(10):522-30. PubMed ID: 22795313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
    Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
    Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
    Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts.
    Geurts J; van den Brand BT; Wolf A; Abdollahi-Roodsaz S; Arntz OJ; Kracht M; van den Berg WB; van de Loo FA
    Rheumatology (Oxford); 2011 Jul; 50(7):1216-25. PubMed ID: 21335610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-mediated activation of TAK1 and IKK.
    Adhikari A; Xu M; Chen ZJ
    Oncogene; 2007 May; 26(22):3214-26. PubMed ID: 17496917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive association of TGF-beta-activated kinase 1 with the IkappaB kinase complex in the nucleus and cytoplasm of human neutrophils and its impact on downstream processes.
    Ear T; Fortin CF; Simard FA; McDonald PP
    J Immunol; 2010 Apr; 184(7):3897-906. PubMed ID: 20200282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential function for the kinase TAK1 in innate and adaptive immune responses.
    Sato S; Sanjo H; Takeda K; Ninomiya-Tsuji J; Yamamoto M; Kawai T; Matsumoto K; Takeuchi O; Akira S
    Nat Immunol; 2005 Nov; 6(11):1087-95. PubMed ID: 16186825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
    Santoro R; Carbone C; Piro G; Chiao PJ; Melisi D
    Drug Resist Updat; 2017 Nov; 33-35():36-42. PubMed ID: 29145973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism.
    Sakurai H; Shigemori N; Hasegawa K; Sugita T
    Biochem Biophys Res Commun; 1998 Feb; 243(2):545-9. PubMed ID: 9480845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stercurensin inhibits nuclear factor-κB-dependent inflammatory signals through attenuation of TAK1-TAB1 complex formation.
    Kim YJ; Kim HC; Ko H; Amor EC; Lee JW; Yang HO
    J Cell Biochem; 2011 Feb; 112(2):548-58. PubMed ID: 21268076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner.
    Gottar-Guillier M; Dodeller F; Huesken D; Iourgenko V; Mickanin C; Labow M; Gaveriaux S; Kinzel B; Mueller M; Alitalo K; Littlewood-Evans A; Cenni B
    J Immunol; 2011 May; 186(10):6014-23. PubMed ID: 21471444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAK1 selective inhibition: state of the art and future opportunities.
    Kilty I; Jones LH
    Future Med Chem; 2015; 7(1):23-33. PubMed ID: 25582331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia outer protein P suppresses TGF-beta-activated kinase-1 activity to impair innate immune signaling in Yersinia enterocolitica-infected cells.
    Haase R; Richter K; Pfaffinger G; Courtois G; Ruckdeschel K
    J Immunol; 2005 Dec; 175(12):8209-17. PubMed ID: 16339560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of nuclear factor-kappaB activation through TAK1 and NIK by diesel exhaust particles in L2 cell lines.
    Yun YP; Joo JD; Lee JY; Nam HY; Kim YH; Lee KH; Lim CS; Kim HJ; Lim YG; Lim Y
    Toxicol Lett; 2005 Feb; 155(2):337-42. PubMed ID: 15603929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAK1, more than just innate immunity.
    Dai L; Aye Thu C; Liu XY; Xi J; Cheung PC
    IUBMB Life; 2012 Oct; 64(10):825-34. PubMed ID: 22941947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity.
    Delaney JR; Mlodzik M
    Cell Cycle; 2006 Dec; 5(24):2852-5. PubMed ID: 17218788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell type-specific function of TAK1 in innate immune signaling.
    Ajibade AA; Wang HY; Wang RF
    Trends Immunol; 2013 Jul; 34(7):307-16. PubMed ID: 23664135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of TGF-β-activated kinase 1 as a possible novel target for renal cell carcinoma intervention.
    Meng F; Li Y; Tian X; Fu L; Yin Y; Sui C; Ma P; Jiang Y
    Biochem Biophys Res Commun; 2014 Oct; 453(1):106-11. PubMed ID: 25261726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK1 regulates hepatic cell survival and carcinogenesis.
    Roh YS; Song J; Seki E
    J Gastroenterol; 2014 Feb; 49(2):185-94. PubMed ID: 24443058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CALML6 Controls TAK1 Ubiquitination and Confers Protection against Acute Inflammation.
    Sheng C; Wang Z; Yao C; Chen HM; Kan G; Wang D; Chen H; Chen S
    J Immunol; 2020 Jun; 204(11):3008-3018. PubMed ID: 32303555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.